NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/04/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Clifford D. Hyra FRESH IP PLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations and substances, namely, pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Pharmaceutical preparations and substances, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals, and preparations in the nature of medicated wheat-free and gluten-free pasta, crackers for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Medical preparations and substances, namely, fungal preparations in the nature of fungal medications for medical purposes, probiotic preparations for medical use, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Veterinary preparations and substances, namely, fungal preparations in the nature of fungal medications for veterinary purposes; Veterinary preparations in the nature of veterinary pharmaceutical preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Biologicals preparations for medical and veterinary use, namely, biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Diagnostic and therapeutic preparations for pharmaceutical, medical and veterinary purposes, namely, diagnostic preparations for veterinary and medical use, pharmaceutical preparations and biological preparations for the treatment, mitigation, diagnosis, or prevention of diseases, conditions, and symptoms related to metabolism, allergies, immune and inflammatory diseases, infectious diseases, the cardiovascular system, the pulmonary system, the respiratory system, oncology, dermatology, the gastrointestinal system, topical illnesses, neurology, endocrinology, the urological system, the reproductive system, nutritional needs, ophthalmic system, renal system, blood and blood-related disorders, integumentary and lymphatic systems in humans and animals; Cultures for pharmaceutical, medical and veterinary purposes, namely, diagnostic media for fungal cultures and cultures of microorganisms, all for medical or veterinary purposes; Preparations and substances for use in drug discovery, namely, sterilizing preparations, growth media preparations in the nature of cell growth media for growing cells for medical and veterinary purposes, and reagents and media for medical and veterinary diagnostic purposes, namely, such media and reagents serving as inoculate, clinical medical reagents, and diagnostic reagents
Classe 42
Science and technology services, namely, scientific and technological research in the field of pharmaceuticals, medical science, biotechnology, the food and animal feed industries, veterinary science, manufacturing of biological preparations, and in the field of industrial biotechnology; Natural science services, namely, scientific research and medical research in the fields of bacteriological, fungal, chemical, bio-technical and pharmacological research services; Clinical research, namely, scientific research in the nature of conducting clinical trials for others; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/04/2025
REGISTERED-PRINCIPAL REGISTER
29/04/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2025
PUBLISHED FOR OPPOSITION
11/03/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2025
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
19/12/2024
APPROVED FOR PUB - PRINCIPAL REGISTER
13/12/2024
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
30/08/2024
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
30/08/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
30/08/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/08/2024
TEAS REQUEST FOR RECONSIDERATION RECEIVED
30/08/2024
NOTIFICATION OF FINAL REFUSAL EMAILED
31/05/2024
FINAL REFUSAL E-MAILED
31/05/2024
FINAL REFUSAL WRITTEN
31/05/2024
TEAS/EMAIL CORRESPONDENCE ENTERED
05/12/2023
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/12/2023
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2023
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/09/2023
NON-FINAL ACTION E-MAILED
14/09/2023
NON-FINAL ACTION WRITTEN
14/09/2023
ASSIGNED TO EXAMINER
12/09/2023
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/04/2023
NEW APPLICATION ENTERED
04/04/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.